Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 04:09 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Desflurane Versus Isoflurane for Speeding Postanesthetic Recovery and Hospital Discharge
NCT06252207 · The Cleveland Clinic · NA · withdrawn · last registry update 2026-03-05 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Study Sponsor Decision” | – | Registry record, The Cleveland Clinic |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against GLRA1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-11-10Also stopped (terminated): Negovsky Reanimatology Research Institute, Sevoflurane + Propofol (NCT05259631)
- 2026-10-29Phase 3 first posted: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Sevoflurane + propofol (drug) (NCT07902791)
- 2026-10-23Also stopped (terminated): Ciusss de L'Est de l'Île de Montréal, Dexmedetomidine + Placebo (NCT05615194)
- 2026-10-13Phase 3 first posted: Assiut University, Lidocaine + 0.9% Normal Saline (NCT07871266)
- 2026-10-05Results posted on the registry: Ankara City Hospital Bilkent, Sevoflurane (Volatile Anesthetic) + Propofol 1% (NCT07092046)
- 2026-08-21Also stopped (withdrawn): The University of Hong Kong, Propofol + Sevoflurane (NCT04002271)
- 2026-08-14Results posted on the registry: Milton S. Hershey Medical Center, Hybrid anesthesia (propofol + sevoflurane) + Propofol only TIVA (NCT05759481)
- 2026-07-23Results posted on the registry: University of Florida, TIVA + Balanced anesthesia (NCT04281017)
- 2026-06-30Also stopped (withdrawn): Jacques E. Chelly, Opioid-free anesthesia + Opioid-based anesthesia (NCT07211399)
- 2026-03-24Results posted on the registry: Sedana Medical, Isoflurane + Propofol (NCT05312385)
- 2026-03-03Results posted on the registry: Sedana Medical, Isoflurane + Propofol (NCT05327296)
- 2026-02-25Results posted on the registry: Hospital dos Lusíadas, Opioid-Based Anesthesia (Remifentanil-Based Protocol) + Opioid-Free Anesthesia (Dexmedetomidine-Ketamine-Lidocaine Protocol) (NCT07337135)
- 2026-02-10Also stopped (terminated): University Hospital, Rouen, Prolonged sedation with isoflurane + Prolonged sedation with midazolam (NCT04710914)
- 2025-12-31Results posted on the registry: VA Pittsburgh Healthcare System, Propofol + Sevoflurane (NCT02527083)
- 2025-12-23Phase 3 first posted: Ain Shams University, Balanced anesthesia + Lidocaine spray (NCT07299630)
- 2025-12-17Phase 3 first posted: Hopital Charles Nicolle, Sevoflurane + Desflurane (NCT07289945)
- 2025-11-26Results posted on the registry: Beth Israel Deaconess Medical Center, Ropivacaine + Ketamine (NCT05279898)
- 2025-10-01Results posted on the registry: Institut Bergonié, a drug against GLRA1 (NCT01754597)
- 2025-09-11Phase 3 first posted: University Hospital, Grenoble, Volatile anesthetic + Opioid Anesthesia (NCT07166991)
- 2025-08-12Phase 3 first posted: Xijing Hospital, Desflurane group + Propofol group (NCT07116733)
- 2025-08-01Phase 3 first posted: Assistance Publique - Hôpitaux de Paris, Inahled Isoflurane + Propofol, midazolam (NCT07099014)
- 2025-07-28Results posted on the registry: University of Texas Southwestern Medical Center, Rocuronium + Sugammadex (NCT06225466)
- 2025-07-20Results posted on the registry: West Virginia University, Sugammadex + neostigmine (NCT03111121)
- 2025-06-08Phase 3 first posted: Hany Mohammed El-Hadi Shoukat Mohammed, Group (E): receive aminophylline early intraoperatively, + Group (L) received aminophylline late intraoperatively (NCT07011134)
- 2025-05-30Phase 3 first posted: Dr. Asma Abdus Salam, Nalbuphine Injection + Next Generation Sequencing (NCT06996561)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision